CID 16198982
| Internal ID | b4398363-9344-4503-a1e9-ce46cdcbcb0c |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | 22-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-34-chloro-25-(3,5-dihydroxyphenyl)-38,51-dihydroxy-23,26,29,44,46-pentaoxo-7,36-dioxa-18,24,27,30,43,45-hexazanonacyclo[29.13.2.23,6.232,35.18,12.113,17.137,41.010,28.016,20]tripentaconta-3(53),4,6(52),8,10,12(51),13(50),14,16,19,32,34,37,39,41(47),48-hexadecaene-42-carboxylic acid |
| SMILES (Canonical) | C1C2C(=O)NC(C3=CC(=C(C=C3)O)OC4=C(C=C(C=C4)C(C(=O)N2)NC(=O)C5C6=CC(=C(C(=C6)OC7=CC=C1C=C7)O)C8=CC9=C(C=C8)C(=CN9)CC(C(=O)NC(C(=O)N5)C1=CC(=CC(=C1)O)O)NC(=O)C(CC1=CC=C(C=C1)O)N)Cl)C(=O)O |
| SMILES (Isomeric) | C1C2C(=O)NC(C3=CC(=C(C=C3)O)OC4=C(C=C(C=C4)C(C(=O)N2)NC(=O)C5C6=CC(=C(C(=C6)OC7=CC=C1C=C7)O)C8=CC9=C(C=C8)C(=CN9)CC(C(=O)NC(C(=O)N5)C1=CC(=CC(=C1)O)O)NC(=O)C(CC1=CC=C(C=C1)O)N)Cl)C(=O)O |
| InChI | InChI=1S/C61H51ClN8O15/c62-41-20-30-7-14-47(41)85-48-23-31(6-13-46(48)74)53(61(82)83)70-56(77)44-16-28-3-10-38(11-4-28)84-49-24-33-19-40(54(49)75)29-5-12-39-34(26-64-43(39)21-29)22-45(65-55(76)42(63)15-27-1-8-35(71)9-2-27)57(78)67-51(32-17-36(72)25-37(73)18-32)59(80)69-52(33)60(81)68-50(30)58(79)66-44/h1-14,17-21,23-26,42,44-45,50-53,64,71-75H,15-16,22,63H2,(H,65,76)(H,66,79)(H,67,78)(H,68,81)(H,69,80)(H,70,77)(H,82,83) |
| InChI Key | UFHMIPMOTWJTKL-UHFFFAOYSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C61H51ClN8O15 |
| Molecular Weight | 1171.60 g/mol |
| Exact Mass | 1170.3162406 g/mol |
| Topological Polar Surface Area (TPSA) | 373.00 Ų |
| XlogP | 3.30 |
| Atomic LogP (AlogP) | 5.38 |
| H-Bond Acceptor | 15 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 6 |
| 22-[[2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]-34-chloro-25-(3,5-dihydroxyphenyl)-38,51-dihydroxy-23,26,29,44,46-pentaoxo-7,36-dioxa-18,24,27,30,43,45-hexazanonacyclo[29.13.2.23,6.232,35.18,12.113,17.137,41.010,28.016,20]tripentaconta-3(53),4,6(52),8,10,12(51),13(50),14,16,19,32,34,37,39,41(47),48-hexadecaene-42-carboxylic acid |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8620 | 86.20% |
| Caco-2 | - | 0.8665 | 86.65% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.7143 | 71.43% |
| Subcellular localzation | Nucleus | 0.5377 | 53.77% |
| OATP2B1 inhibitior | - | 0.5816 | 58.16% |
| OATP1B1 inhibitior | + | 0.8405 | 84.05% |
| OATP1B3 inhibitior | + | 0.9347 | 93.47% |
| MATE1 inhibitior | - | 0.8009 | 80.09% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.9792 | 97.92% |
| P-glycoprotein inhibitior | + | 0.7452 | 74.52% |
| P-glycoprotein substrate | + | 0.8237 | 82.37% |
| CYP3A4 substrate | + | 0.7409 | 74.09% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8096 | 80.96% |
| CYP3A4 inhibition | - | 0.7224 | 72.24% |
| CYP2C9 inhibition | - | 0.8355 | 83.55% |
| CYP2C19 inhibition | - | 0.7683 | 76.83% |
| CYP2D6 inhibition | - | 0.7252 | 72.52% |
| CYP1A2 inhibition | - | 0.7484 | 74.84% |
| CYP2C8 inhibition | + | 0.8572 | 85.72% |
| CYP inhibitory promiscuity | - | 0.6313 | 63.13% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7200 | 72.00% |
| Carcinogenicity (trinary) | Non-required | 0.4623 | 46.23% |
| Eye corrosion | - | 0.9895 | 98.95% |
| Eye irritation | - | 0.9005 | 90.05% |
| Skin irritation | - | 0.7876 | 78.76% |
| Skin corrosion | - | 0.9406 | 94.06% |
| Ames mutagenesis | - | 0.5100 | 51.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6620 | 66.20% |
| Micronuclear | + | 0.8800 | 88.00% |
| Hepatotoxicity | - | 0.5476 | 54.76% |
| skin sensitisation | - | 0.8583 | 85.83% |
| Respiratory toxicity | + | 0.8667 | 86.67% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.8000 | 80.00% |
| Nephrotoxicity | - | 0.6722 | 67.22% |
| Acute Oral Toxicity (c) | III | 0.5941 | 59.41% |
| Estrogen receptor binding | + | 0.7786 | 77.86% |
| Androgen receptor binding | + | 0.7713 | 77.13% |
| Thyroid receptor binding | + | 0.6477 | 64.77% |
| Glucocorticoid receptor binding | + | 0.6216 | 62.16% |
| Aromatase binding | + | 0.6460 | 64.60% |
| PPAR gamma | + | 0.7372 | 73.72% |
| Honey bee toxicity | - | 0.6175 | 61.75% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | + | 0.5644 | 56.44% |
| Fish aquatic toxicity | + | 0.8626 | 86.26% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL236 | P41143 | Delta opioid receptor | 99.88% | 99.35% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.78% | 98.95% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.62% | 91.11% |
| CHEMBL233 | P35372 | Mu opioid receptor | 99.57% | 97.93% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 99.11% | 92.29% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.04% | 94.45% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 98.71% | 91.49% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.84% | 96.09% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 96.83% | 99.15% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 95.71% | 91.71% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.15% | 97.09% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 93.66% | 95.58% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.64% | 95.89% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 93.45% | 85.00% |
| CHEMBL1944 | P08473 | Neprilysin | 92.93% | 92.63% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 92.80% | 89.00% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 92.34% | 94.00% |
| CHEMBL242 | Q92731 | Estrogen receptor beta | 91.83% | 98.35% |
| CHEMBL3837 | P07711 | Cathepsin L | 91.56% | 96.61% |
| CHEMBL5339 | Q5NUL3 | G-protein coupled receptor 120 | 91.53% | 95.78% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 91.16% | 85.11% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 90.78% | 96.11% |
| CHEMBL217 | P14416 | Dopamine D2 receptor | 90.75% | 95.62% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 89.40% | 96.76% |
| CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 89.31% | 94.01% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 88.00% | 96.00% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 87.84% | 82.86% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 87.50% | 91.19% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 87.29% | 99.17% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 87.14% | 90.71% |
| CHEMBL2327 | P21452 | Neurokinin 2 receptor | 86.99% | 98.89% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 86.94% | 91.38% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 86.76% | 96.95% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 86.45% | 95.34% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 86.26% | 96.28% |
| CHEMBL2000 | P03952 | Plasma kallikrein | 86.23% | 93.92% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 86.14% | 96.25% |
| CHEMBL1801 | P00747 | Plasminogen | 85.81% | 92.44% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 85.54% | 97.23% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 85.03% | 80.71% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 83.98% | 95.50% |
| CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 83.96% | 92.62% |
| CHEMBL2095226 | P05556 | Integrin alpha-5/beta-1 | 83.66% | 96.39% |
| CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 83.27% | 95.71% |
| CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 83.17% | 100.00% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 83.13% | 97.31% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 82.79% | 89.67% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 82.75% | 95.56% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 82.59% | 92.50% |
| CHEMBL204 | P00734 | Thrombin | 81.18% | 96.01% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 80.64% | 83.10% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 80.62% | 96.90% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 16198982 |
| LOTUS | LTS0096142 |
| wikiData | Q105271859 |